Cardiovascular Systems Stock Price, News & Analysis (NASDAQ:CSII)

$25.98 0.83 (3.30 %)
(As of 01/19/2018 04:00 PM ET)
Previous Close$25.98
Today's Range$25.19 - $26.04
52-Week Range$23.00 - $33.11
Volume225,191 shs
Average Volume187,491 shs
Market Capitalization$858.16 million
P/E Ratio1,257.50
Dividend YieldN/A
Beta2.53

About Cardiovascular Systems (NASDAQ:CSII)

Cardiovascular Systems logoCardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee. Its products include Diamondback 360 Peripheral Orbital Atherectomy System (OAS) (Diamondback 360 Peripheral), the Stealth 360 OAS (Stealth 360), Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral and Diamondback 360 2.00 Peripheral. The Company's coronary arterial disease (CAD) product, Diamondback 360 Coronary OAS (Coronary OAS), is marketed as a treatment for severely calcified coronary arteries.

Receive CSII News and Ratings via Email

Sign-up to receive the latest news and ratings for CSII and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:CSII
CUSIP14161910
Phone651-259-1600

Debt

Debt-to-Equity Ratio0.18%
Current Ratio4.30%
Quick Ratio3.83%

Price-To-Earnings

Trailing P/E Ratio1257.5
Forward P/E Ratio-866.00
P/E GrowthN/A

Sales & Book Value

Annual Sales$204.91 million
Price / Sales4.33
Cash Flow$0.16 per share
Price / Cash161.03
Book Value$3.62 per share
Price / Book7.18

Profitability

Trailing EPS($0.06)
Net Income$-1,790,000.00
Net Margins-0.93%
Return on Equity0.74%
Return on Assets0.47%

Miscellaneous

Employees579
Outstanding Shares34,120,000

Cardiovascular Systems (NASDAQ:CSII) Frequently Asked Questions

What is Cardiovascular Systems' stock symbol?

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems Inc (NASDAQ:CSII) released its quarterly earnings results on Wednesday, October, 25th. The medical device company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.02. The medical device company earned $49.70 million during the quarter, compared to the consensus estimate of $51 million. Cardiovascular Systems had a positive return on equity of 0.74% and a negative net margin of 0.93%. Cardiovascular Systems's revenue was down .2% compared to the same quarter last year. During the same quarter last year, the business posted ($0.06) earnings per share. View Cardiovascular Systems' Earnings History.

When will Cardiovascular Systems make its next earnings announcement?

Cardiovascular Systems is scheduled to release their next quarterly earnings announcement on Wednesday, February, 7th 2018. View Earnings Estimates for Cardiovascular Systems.

What guidance has Cardiovascular Systems issued on next quarter's earnings?

Cardiovascular Systems updated its second quarter earnings guidance on Wednesday, October, 25th. The company provided earnings per share (EPS) guidance of $(0.06)-(0.03) for the period, compared to the Thomson Reuters consensus estimate of $0.00. The company issued revenue guidance of $52.5-54 million, compared to the consensus revenue estimate of $55.11 million.

Where is Cardiovascular Systems' stock going? Where will Cardiovascular Systems' stock price be in 2018?

6 equities research analysts have issued twelve-month target prices for Cardiovascular Systems' shares. Their forecasts range from $23.00 to $40.00. On average, they anticipate Cardiovascular Systems' share price to reach $31.50 in the next year. View Analyst Ratings for Cardiovascular Systems.

What are Wall Street analysts saying about Cardiovascular Systems stock?

Here are some recent quotes from research analysts about Cardiovascular Systems stock:

  • 1. According to Zacks Investment Research, "Cardiovascular Systems exited the first quarter of fiscal 2018 on a mixed note. The earnings compared favorably with the Zacks Consensus Estimate while revenues missed the same. Fiscal first-quarter revenues declined on a year-over-year basis owing to the impact of hurricanes. The company incurred net loss in the reported first quarter. Also, intense competition adds to the woes. On a positive note, despite the decline in revenues, the reaffirmed revenue guidance for fiscal 2018 buoys optimism. The reported net loss in the quarter was narrower than the guided range. Also, the expansion in gross margin was impressive. To note, the company is currently focusing on product innovation through R&D investments. During the quarter, the company released one-year positive data from its LIBERTY 360° clinical study in a late-breaking presentation at the 2017 Amputation Prevention Symposium (AMP) in Chicago." (11/13/2017)
  • 2. Needham & Company LLC analysts commented, "CSII’s F1Q18 revenue and EPS beat consensus though we note that CSII had announced on 9/18/17 that it expected to miss its original guidance due to the hurricanes. F2Q18 revenue and EPS guidance were below consensus although management maintained its FY18 revenue guidance since it expects recent sales force changes to reaccelerate its coronary sales. While CSII faces its most difficult comp in F2Q18, we expect growth to accelerate in CY18 as comps begin to ease, the sales force changes improve coronary sales, CSII launches its coronary product in Japan and support products (such as guide wires) in the US." (10/26/2017)

Who are some of Cardiovascular Systems' key competitors?

Who are Cardiovascular Systems' key executives?

Cardiovascular Systems' management team includes the folowing people:

  • Scott R. Ward, Chairman of the Board, President, Chief Executive Officer (Age 57)
  • Laurence L. Betterley, Chief Financial Officer (Age 63)
  • Sandra Sedo, Chief Compliance Officer (Age 53)
  • Alexander Rosenstein, General Counsel and Corporate Secretary (Age 45)
  • Laura Gillund, Chief Talent Officer (Age 56)
  • Martha Goldberg Aronson, Independent Director (Age 50)
  • Scott A. Bartos, Independent Director (Age 54)
  • Brent G. Blackey, Independent Director (Age 58)
  • Edward M. Brown, Independent Director (Age 54)
  • William E. Cohn M.D., Independent Director (Age 57)

Who owns Cardiovascular Systems stock?

Cardiovascular Systems' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Frontier Capital Management Co. LLC (2.32%), Schwab Charles Investment Management Inc. (0.56%), Thomson Horstmann & Bryant Inc. (0.43%), GW&K Investment Management LLC (0.40%), Bank of Montreal Can (0.16%) and Acadian Asset Management LLC (0.09%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Camber Capital Management Llc, Edward M Brown, Kevin J Kenny, Laura Gillund, Laurence L Betterley, Paul A Koehn and Scott R Ward. View Institutional Ownership Trends for Cardiovascular Systems.

Who sold Cardiovascular Systems stock? Who is selling Cardiovascular Systems stock?

Cardiovascular Systems' stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC and Schwab Charles Investment Management Inc.. Company insiders that have sold Cardiovascular Systems company stock in the last year include Alexander Rosenstein, Edward M Brown, Kevin J Kenny, Laura Gillund, Laurence L Betterley and Scott R Ward. View Insider Buying and Selling for Cardiovascular Systems.

Who bought Cardiovascular Systems stock? Who is buying Cardiovascular Systems stock?

Cardiovascular Systems' stock was purchased by a variety of institutional investors in the last quarter, including Thomson Horstmann & Bryant Inc., GW&K Investment Management LLC, Acadian Asset Management LLC and Bank of Montreal Can. Company insiders that have bought Cardiovascular Systems stock in the last two years include Camber Capital Management Llc and Scott R Ward. View Insider Buying and Selling for Cardiovascular Systems.

How do I buy Cardiovascular Systems stock?

Shares of Cardiovascular Systems can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cardiovascular Systems' stock price today?

One share of Cardiovascular Systems stock can currently be purchased for approximately $25.98.

How big of a company is Cardiovascular Systems?

Cardiovascular Systems has a market capitalization of $858.16 million and generates $204.91 million in revenue each year. The medical device company earns $-1,790,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis. Cardiovascular Systems employs 579 workers across the globe.

How can I contact Cardiovascular Systems?

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The medical device company can be reached via phone at 651-259-1600 or via email at [email protected]


MarketBeat Community Rating for Cardiovascular Systems (CSII)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  244 (Vote Outperform)
Underperform Votes:  156 (Vote Underperform)
Total Votes:  400
MarketBeat's community ratings are surveys of what our community members think about Cardiovascular Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cardiovascular Systems (NASDAQ:CSII) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.002.002.572.83
Ratings Breakdown: 1 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $31.50$31.50$34.25$34.40
Price Target Upside: 31.69% upside31.69% upside20.22% upside8.90% upside

Cardiovascular Systems (NASDAQ:CSII) Consensus Price Target History

Price Target History for Cardiovascular Systems (NASDAQ:CSII)

Cardiovascular Systems (NASDAQ:CSII) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/21/2017William BlairReiterated RatingMarket PerformLowView Rating Details
12/15/2017Needham & Company LLCDowngradeBuy -> Hold$33.11 -> $23.00HighView Rating Details
12/4/2017Raymond James FinancialReiterated RatingHoldLowView Rating Details
9/21/2017CitigroupInitiated CoverageMarket PerformLowView Rating Details
6/21/2017Bank of AmericaDowngradeNeutral -> UnderperformLowView Rating Details
1/30/2017Lake Street CapitalInitiated CoverageBuy$40.00N/AView Rating Details
11/15/2016Leerink SwannReiterated RatingOutperform$30.00N/AView Rating Details
10/27/2016Feltl & Co.UpgradeBuy -> Strong-Buy$30.00N/AView Rating Details
10/7/2016JMP SecuritiesInitiated CoverageOutperform$35.00N/AView Rating Details
(Data available from 1/20/2016 forward)

Earnings

Cardiovascular Systems (NASDAQ:CSII) Earnings History and Estimates Chart

Earnings by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Cardiovascular Systems (NASDAQ CSII) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2018($0.04)N/AView Earnings Details
10/25/2017Q1 2018($0.08)($0.06)$51.00 million$49.70 millionViewN/AView Earnings Details
8/2/2017Q4 2017($0.05)$0.02$51.98 million$52.90 millionViewListenView Earnings Details
5/3/2017Q3 2017($0.05)($0.05)$51.13 million$52.10 millionViewListenView Earnings Details
1/25/2017Q217($0.06)$0.03$49.72 million$50.00 millionViewN/AView Earnings Details
10/26/2016Q117($0.18)($0.06)$205.50 million$49.80 millionViewListenView Earnings Details
8/3/2016Q416($0.20)($0.15)$46.01 million$48.50 millionViewN/AView Earnings Details
5/4/2016Q316($0.54)($0.31)$42.13 million$44.50 millionViewN/AView Earnings Details
1/21/2016Q216($0.50)($0.47)$44.82 million$41.40 millionViewListenView Earnings Details
11/4/2015Q116($0.42)($0.41)$43.90 million$43.90 millionViewN/AView Earnings Details
8/5/2015Q415($0.30)($0.27)$50.10 million$48.50 millionViewN/AView Earnings Details
4/29/2015Q315($0.33)($0.34)$46.84 million$47.00 millionViewListenView Earnings Details
1/28/2015Q215($0.34)($0.17)$43.97 million$44.70 millionViewListenView Earnings Details
10/29/2014Q115($0.33)($0.26)$40.24 million$41.40 millionViewListenView Earnings Details
8/6/2014Q214($0.28)($0.31)$37.21 million$39.56 millionViewListenView Earnings Details
4/30/2014Q114($0.32)($0.32)$34.15 million$34.90 millionViewListenView Earnings Details
1/29/2014Q2($0.34)($0.32)$30.62 million$32.30 millionViewListenView Earnings Details
10/30/2013Q1 2014($0.40)($0.29)ViewN/AView Earnings Details
8/7/2013Q4 2013($0.30)($0.28)$27.18 million$28.80 millionViewListenView Earnings Details
5/1/2013Q3 2013($0.33)($0.27)ViewN/AView Earnings Details
1/30/2013Q2 2013($0.31)($0.27)ViewN/AView Earnings Details
10/30/2012Q1 2013($0.34)($0.26)ViewN/AView Earnings Details
8/8/2012Q4 2012($0.26)($0.24)ViewN/AView Earnings Details
5/2/2012Q3 2012($0.25)($0.23)ViewN/AView Earnings Details
2/7/2012Q2 2012($0.20)($0.23)ViewN/AView Earnings Details
11/2/2011Q1 2012($0.24)($0.20)ViewN/AView Earnings Details
8/3/2011Q4 2011($0.07)($0.07)ViewN/AView Earnings Details
5/4/2011Q3 2011($0.14)($0.15)ViewN/AView Earnings Details
2/2/2011Q2 2011($0.19)($0.13)ViewN/AView Earnings Details
11/3/2010Q1 2011($0.35)($0.28)ViewN/AView Earnings Details
8/10/2010Q4 2010($0.40)($0.29)ViewN/AView Earnings Details
5/5/2010Q3 2010($0.47)($0.44)ViewN/AView Earnings Details
2/3/2010Q2 2010($0.49)($0.46)ViewN/AView Earnings Details
11/4/2009Q1 2010($0.43)($0.43)ViewN/AView Earnings Details
8/19/2009Q4 2009($0.58)($0.40)ViewN/AView Earnings Details
5/6/2009Q3 2009($0.88)$1.82ViewN/AView Earnings Details
8/5/2008Q4 2008($3.10)($6.93)ViewN/AView Earnings Details
5/7/2008Q3 2008($5.60)($3.32)ViewN/AView Earnings Details
2/26/2008Q2 2008($4.00)($6.32)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Cardiovascular Systems (NASDAQ:CSII) Earnings Estimates

2018 EPS Consensus Estimate: $0.10
2019 EPS Consensus Estimate: $0.14
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20184($0.08)$0.00($0.02)
Q2 20184($0.05)$0.03$0.01
Q3 20183$0.04$0.05$0.04
Q4 20184$0.05$0.09$0.08
Q1 20191($0.05)($0.05)($0.05)
Q2 20191$0.00$0.00$0.00
Q3 20191$0.09$0.09$0.09
Q4 20191$0.10$0.10$0.10
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Cardiovascular Systems (NASDAQ:CSII)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Cardiovascular Systems (NASDAQ CSII) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.30%
Institutional Ownership Percentage: 74.86%
Insider Trades by Quarter for Cardiovascular Systems (NASDAQ:CSII)
Institutional Ownership by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Cardiovascular Systems (NASDAQ CSII) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/31/2017Edward M BrownDirectorSell20,000$29.16$583,200.00View SEC Filing  
8/30/2017Edward M BrownDirectorSell13,031$29.09$379,071.79View SEC Filing  
8/17/2017Laura GillundInsiderSell2,350$30.42$71,487.0088,633View SEC Filing  
8/17/2017Scott R WardCEOSell5,529$30.41$168,136.89282,536View SEC Filing  
8/16/2017Alexander RosensteinGeneral CounselSell979$30.71$30,065.0952,296View SEC Filing  
8/16/2017Kevin J KennyCOOSell4,733$30.74$145,492.42153,339View SEC Filing  
8/16/2017Laurence L BetterleyCFOSell4,443$30.74$136,577.82223,557View SEC Filing  
5/17/2017Alexander RosensteinGeneral CounselSell219$32.30$7,073.7034,265View SEC Filing  
11/18/2016Alexander RosensteinGeneral CounselSell529$26.80$14,177.2034,484View SEC Filing  
11/18/2016Edward M BrownDirectorSell10,000$26.78$267,800.00View SEC Filing  
11/18/2016Laura GillundInsiderSell1,268$26.79$33,969.7269,541View SEC Filing  
11/15/2016Edward M BrownDirectorSell10,000$24.95$249,500.00View SEC Filing  
10/10/2016Paul A KoehnSVPSell30,910$25.07$774,913.70110,200View SEC Filing  
9/20/2016Camber Capital Management LlcMajor ShareholderSell1,100,000$23.26$25,586,000.00View SEC Filing  
9/7/2016Paul A KoehnSVPSell5,969$25.02$149,344.3873,321View SEC Filing  
8/22/2016Alexander RosensteinGeneral CounselSell234$23.82$5,573.8838,035View SEC Filing  
8/22/2016Kevin J KennyCOOSell3,166$23.95$75,825.70168,231View SEC Filing  
8/22/2016Laura GillundInsiderSell1,395$23.93$33,382.3582,817View SEC Filing  
8/22/2016Laurence L BetterleyCFOSell3,568$23.96$85,489.28253,031View SEC Filing  
8/22/2016Paul A KoehnSVPSell2,527$23.92$60,445.84100,125View SEC Filing  
8/17/2016Paul A KoehnSVPSell4,000$22.17$88,680.00102,652View SEC Filing  
2/26/2016Paul A KoehnSVPSell956$38.79$37,083.2473,266View SEC Filing  
2/23/2016Camber Capital Management LlcMajor ShareholderBuy250,000$7.55$1,887,500.00View SEC Filing  
1/25/2016Scott R WardCEOBuy2,700$9.30$25,110.009,533View SEC Filing  
10/2/2015Robert J. ThatcherinsiderSell64,700$16.31$1,055,257.00126,978View SEC Filing  
9/2/2015David MartinCEOSell19,646$23.81$467,771.26458,818View SEC Filing  
9/1/2015Kevin J KennyCOOSell5,289$23.85$126,142.65105,330View SEC Filing  
9/1/2015Laurence L BetterleyCFOSell9,597$23.96$229,944.12191,414View SEC Filing  
9/1/2015Paul A KoehnSVPSell4,946$23.86$118,011.5673,738View SEC Filing  
9/1/2015Robert J ThatcherInsiderSell5,282$23.85$125,975.70126,978View SEC Filing  
8/18/2015David MartinCEOSell17,688$23.99$424,335.12View SEC Filing  
8/18/2015Kevin J. KennyCOOSell3,913$24.00$93,912.00117,458View SEC Filing  
8/18/2015Laurence L BetterleyCFOSell8,476$24.00$203,424.00View SEC Filing  
8/18/2015Paul A. KoehnSVPSell4,402$23.99$105,603.9884,439View SEC Filing  
8/18/2015Robert J. ThatcherinsiderSell2,960$23.99$71,010.40138,243View SEC Filing  
8/12/2015Brent G BlackeyDirectorBuy2,500$22.74$56,850.00View SEC Filing  
5/28/2015Paul A KoehnSVPSell4,389$27.86$122,277.54View SEC Filing  
5/1/2015Brent G BlackeyDirectorBuy2,500$29.38$73,450.00View SEC Filing  
2/10/2015David MartinCEOSell7,500$35.85$268,875.00View SEC Filing  
2/5/2015David MartinCEOSell4,500$34.96$157,320.00View SEC Filing  
1/29/2015Kevin J KennyVPSell4,212$35.00$147,420.00View SEC Filing  
9/3/2014David MartinCEOSell10,248$28.85$295,654.80View SEC Filing  
9/3/2014Kevin J KennyVPSell3,528$28.85$101,782.80View SEC Filing  
9/3/2014Laurence L BetterleyCFOSell4,674$28.82$134,704.68View SEC Filing  
9/3/2014Paul A KoehnSVPSell2,612$28.85$75,356.20View SEC Filing  
9/3/2014Robert J ThatcherInsiderSell2,791$28.85$80,520.35View SEC Filing  
8/28/2014Paul A KoehnSVPSell1,315$28.82$37,898.30View SEC Filing  
8/22/2014David MartinCEOSell13,957$29.03$405,171.71View SEC Filing  
8/22/2014Kevin J KennyVPSell2,914$29.09$84,768.26View SEC Filing  
8/22/2014Laurence L BetterleyCFOSell6,578$29.02$190,893.56View SEC Filing  
8/22/2014Paul A KoehnSVPSell2,755$29.06$80,060.30View SEC Filing  
8/22/2014Robert J ThatcherInsiderSell3,225$29.06$93,718.50View SEC Filing  
8/19/2014David MartinCEOSell11,754$29.28$344,157.12View SEC Filing  
8/19/2014Kevin J KennyVPSell2,117$29.28$61,985.76View SEC Filing  
8/19/2014Laurence L BetterleyCFOSell5,725$29.28$167,628.00View SEC Filing  
8/19/2014Paul A KoehnSVPSell2,168$29.28$63,479.04View SEC Filing  
8/19/2014Robert J ThatcherInsiderSell2,537$29.28$74,283.36View SEC Filing  
7/16/2014David MartinCEOSell10,703$28.83$308,567.49View SEC Filing  
7/16/2014Kevin J KennyVPSell3,007$28.83$86,691.81View SEC Filing  
7/16/2014Laurence L BetterleyCFOSell3,984$28.83$114,858.72View SEC Filing  
7/16/2014Paul A KoehnSVPSell2,716$28.83$78,302.28View SEC Filing  
7/16/2014Robert J ThatcherInsiderSell2,939$28.83$84,731.37View SEC Filing  
4/25/2014Kevin KennyVPSell15,484$28.79$445,784.3666,841View SEC Filing  
2/24/2014David MartinCEOSell29,200$37.31$1,089,452.00354,052View SEC Filing  
2/20/2014Kevin KennyVPSell6,779$36.02$244,179.5882,325View SEC Filing  
1/30/2014David MartinCEOSell50,000$35.12$1,756,000.00354,052View SEC Filing  
1/30/2014Robert ThatcherVPSell35,139$35.06$1,231,973.3484,014View SEC Filing  
11/22/2013Robert ThatcherVPSell22,384$32.82$734,642.8884,014View SEC Filing  
10/31/2013James E FlahertyInsiderSell34,819$30.35$1,056,756.65View SEC Filing  
10/23/2013David MartinCEOSell154,080$27.73$4,272,638.40View SEC Filing  
10/23/2013James E FlahertyInsiderSell36,682$26.85$984,911.70View SEC Filing  
10/23/2013Robert J ThatcherVPSell23,426$28.19$660,378.94View SEC Filing  
10/22/2013Kevin J KennyVPSell5,608$27.31$153,154.48View SEC Filing  
10/16/2013Kevin J KennyVPSell4,182$22.95$95,976.90View SEC Filing  
10/14/2013David MartinCEOSell21,170$22.00$465,740.00354,052View SEC Filing  
9/20/2013David MartinCEOSell6,702$20.24$135,648.48354,052View SEC Filing  
9/20/2013James FlahertyInsiderSell2,066$20.28$41,898.48140,736View SEC Filing  
9/20/2013Robert ThatcherVPSell1,274$20.28$25,836.72130,105View SEC Filing  
9/19/2013Laurence BetterleyCFOSell2,694$20.32$54,742.08203,362View SEC Filing  
9/19/2013Paul KoehnSVPSell1,094$20.32$22,230.0859,074View SEC Filing  
9/18/2013David MartinCEOSell8,030$20.94$168,148.20360,754View SEC Filing  
9/18/2013James FlahertyInsiderSell2,970$20.94$62,191.80142,802View SEC Filing  
9/18/2013Laurence BetterleyCFOSell4,324$20.93$90,501.32206,056View SEC Filing  
9/18/2013Paul KoehnSVPSell1,732$20.93$36,250.7660,168View SEC Filing  
9/18/2013Robert ThatcherVPSell1,731$20.94$36,247.14131,379View SEC Filing  
9/10/2013John FriedmanDirectorSell48,273$20.73$1,000,699.298,000View SEC Filing  
8/30/2013David MartinCEOSell21,552$20.64$444,833.28297,649View SEC Filing  
8/30/2013James FlahertyInsiderSell7,165$20.64$147,885.60122,329View SEC Filing  
8/30/2013Kevin KennyVPSell1,899$20.64$39,195.3687,780View SEC Filing  
8/30/2013Laurence BetterleyCFOSell8,692$20.64$179,402.88177,554View SEC Filing  
8/27/2013David MartinCEOSell27,229$21.07$573,715.03319,201View SEC Filing  
8/27/2013James FlahertyInsiderSell9,051$21.07$190,704.57129,494View SEC Filing  
8/27/2013Kevin KennyVPSell2,396$21.07$50,483.7289,679View SEC Filing  
8/27/2013Laurence BetterleyCFOSell10,982$21.07$231,390.74186,246View SEC Filing  
8/16/2013James FlahertyInsiderSell1,255$20.51$25,740.05138,545View SEC Filing  
8/16/2013Laurence BetterleyCFOSell1,568$20.51$32,159.68197,228View SEC Filing  
8/14/2013James FlahertyInsiderSell4,902$21.31$104,461.62139,800View SEC Filing  
8/13/2013Kevin KennyVPSell2,529$21.20$53,614.8092,723View SEC Filing  
8/8/2013James FlahertyInsiderSell19,649$22.27$437,583.23120,282View SEC Filing  
7/30/2013David MartinCEOSell11,094$19.69$218,440.86View SEC Filing  
7/30/2013Laurence L BetterleyCFOSell6,579$19.72$129,737.88View SEC Filing  
7/30/2013Robert J ThatcherVPSell3,112$19.86$61,804.32View SEC Filing  
6/3/2013James E FlahertyInsiderSell10,000$21.00$210,000.00View SEC Filing  
5/31/2013Paul A KoehnVPSell2,472$20.00$49,440.00View SEC Filing  
5/28/2013Kevin J KennyVPSell4,182$19.95$83,430.90View SEC Filing  
5/20/2013Glen D NelsonDirectorBuy10,250$18.47$189,317.50View SEC Filing  
5/16/2013Glen D NelsonDirectorBuy4,753$18.93$89,974.29View SEC Filing  
5/13/2013Glen D NelsonDirectorBuy18,393$18.11$333,097.23View SEC Filing  
11/13/2012Glen D NelsonDirectorBuy33,000$11.96$394,680.00View SEC Filing  
8/23/2012David MartinCEOSell10,510$9.07$95,325.70View SEC Filing  
8/23/2012James E FlahertyInsiderSell4,018$9.07$36,443.26View SEC Filing  
8/23/2012Laurence L BetterleyCFOSell4,770$9.07$43,263.90View SEC Filing  
8/23/2012Paul A KoehnVPSell2,496$9.07$22,638.72View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cardiovascular Systems (NASDAQ CSII) News Headlines

Source:
DateHeadline
Positive Market Trends Aid Cardiovascular Systems Amid Woes - NasdaqPositive Market Trends Aid Cardiovascular Systems Amid Woes - Nasdaq
www.nasdaq.com - January 18 at 4:42 PM
Cardiovascular Systems Expands Product Portfolio to Further Support Peripheral and Coronary Interventions - Business Wire (press release)Cardiovascular Systems Expands Product Portfolio to Further Support Peripheral and Coronary Interventions - Business Wire (press release)
www.businesswire.com - January 18 at 4:42 PM
Cardiovascular Systems Expands Product Portfolio to Further Support Peripheral and Coronary InterventionsCardiovascular Systems Expands Product Portfolio to Further Support Peripheral and Coronary Interventions
finance.yahoo.com - January 18 at 10:36 AM
 Analysts Expect Cardiovascular Systems Inc (CSII) Will Announce Quarterly Sales of $53.26 Million Analysts Expect Cardiovascular Systems Inc (CSII) Will Announce Quarterly Sales of $53.26 Million
www.americanbankingnews.com - January 12 at 4:42 AM
Comparing Cardiovascular Systems (CSII) and LDR (LDRH)Comparing Cardiovascular Systems (CSII) and LDR (LDRH)
www.americanbankingnews.com - January 10 at 11:14 PM
Cardiovascular Systems Inc (CSII) Receives Average Rating of "Hold" from AnalystsCardiovascular Systems Inc (CSII) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - January 5 at 3:32 AM
BidaskClub Lowers Cardiovascular Systems (CSII) to Strong SellBidaskClub Lowers Cardiovascular Systems (CSII) to Strong Sell
www.americanbankingnews.com - December 27 at 9:04 PM
Reviewing K2M Group (KTWO) and Cardiovascular Systems (CSII)Reviewing K2M Group (KTWO) and Cardiovascular Systems (CSII)
www.americanbankingnews.com - December 26 at 4:08 PM
Cardiovascular Systems Inc (CSII) Forecasted to Post FY2018 Earnings of $0.02 Per ShareCardiovascular Systems Inc (CSII) Forecasted to Post FY2018 Earnings of $0.02 Per Share
www.americanbankingnews.com - December 25 at 11:56 AM
 Analysts Anticipate Cardiovascular Systems Inc (CSII) Will Post Earnings of -$0.04 Per Share Analysts Anticipate Cardiovascular Systems Inc (CSII) Will Post Earnings of -$0.04 Per Share
www.americanbankingnews.com - December 25 at 8:26 AM
Cardiovascular Systems (CSII) Earns Hold Rating from Analysts at William BlairCardiovascular Systems (CSII) Earns Hold Rating from Analysts at William Blair
www.americanbankingnews.com - December 21 at 10:38 AM
Cardiovascular Systems (CSII) vs. Exactech (EXAC) Critical ContrastCardiovascular Systems (CSII) vs. Exactech (EXAC) Critical Contrast
www.americanbankingnews.com - December 19 at 11:24 PM
ETFs with exposure to Cardiovascular Systems, Inc. : December 18, 2017ETFs with exposure to Cardiovascular Systems, Inc. : December 18, 2017
finance.yahoo.com - December 18 at 5:06 PM
Cardiovascular Systems (CSII) Downgraded by Needham & Company LLCCardiovascular Systems (CSII) Downgraded by Needham & Company LLC
www.americanbankingnews.com - December 15 at 10:40 AM
Q1 2019 Earnings Forecast for Cardiovascular Systems Inc (CSII) Issued By Leerink SwannQ1 2019 Earnings Forecast for Cardiovascular Systems Inc (CSII) Issued By Leerink Swann
www.americanbankingnews.com - December 13 at 9:58 PM
Cardiovascular Systems, Inc. (CSII) Receives Consensus Rating of "Hold" from BrokeragesCardiovascular Systems, Inc. (CSII) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - December 11 at 3:38 AM
 Analysts Anticipate Cardiovascular Systems, Inc. (CSII) to Announce -$0.04 EPS Analysts Anticipate Cardiovascular Systems, Inc. (CSII) to Announce -$0.04 EPS
www.americanbankingnews.com - December 7 at 3:38 PM
ETFs with exposure to Cardiovascular Systems, Inc. : December 5, 2017ETFs with exposure to Cardiovascular Systems, Inc. : December 5, 2017
finance.yahoo.com - December 5 at 5:05 PM
Cardiovascular Systems (CSII) Hold Rating Reiterated at Raymond James FinancialCardiovascular Systems' (CSII) Hold Rating Reiterated at Raymond James Financial
www.americanbankingnews.com - December 5 at 1:30 PM
Comparing Covidien (COV) & Cardiovascular Systems (CSII)Comparing Covidien (COV) & Cardiovascular Systems (CSII)
www.americanbankingnews.com - November 27 at 10:10 AM
Zacks: Analysts Anticipate Cardiovascular Systems, Inc. (CSII) Will Post Quarterly Sales of $53.25 MillionZacks: Analysts Anticipate Cardiovascular Systems, Inc. (CSII) Will Post Quarterly Sales of $53.25 Million
www.americanbankingnews.com - November 21 at 4:42 AM
ETFs with exposure to Cardiovascular Systems, Inc. : November 20, 2017ETFs with exposure to Cardiovascular Systems, Inc. : November 20, 2017
finance.yahoo.com - November 20 at 6:35 PM
Cardiovascular Systems, Inc. (CSII) Given Consensus Recommendation of "Hold" by AnalystsCardiovascular Systems, Inc. (CSII) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - November 16 at 3:38 AM
Cardiovascular Systems, Inc. (CSII) Upgraded to "Hold" at Zacks Investment ResearchCardiovascular Systems, Inc. (CSII) Upgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - November 13 at 12:41 PM
ETFs with exposure to Cardiovascular Systems, Inc. : November 8, 2017ETFs with exposure to Cardiovascular Systems, Inc. : November 8, 2017
finance.yahoo.com - November 8 at 10:42 PM
Cardiovascular Systems, Inc. :CSII-US: Earnings Analysis: Q1, 2018 By the Numbers : November 7, 2017Cardiovascular Systems, Inc. :CSII-US: Earnings Analysis: Q1, 2018 By the Numbers : November 7, 2017
finance.yahoo.com - November 8 at 12:13 AM
 Analysts Anticipate Cardiovascular Systems, Inc. (CSII) Will Post Quarterly Sales of $53.25 Million Analysts Anticipate Cardiovascular Systems, Inc. (CSII) Will Post Quarterly Sales of $53.25 Million
www.americanbankingnews.com - November 1 at 5:54 PM
Contrasting Cardiovascular Systems (CSII) and The CompetitionContrasting Cardiovascular Systems (CSII) and The Competition
www.americanbankingnews.com - November 1 at 1:20 AM
Q2 2018 Earnings Forecast for Cardiovascular Systems, Inc. Issued By Leerink Swann (CSII)Q2 2018 Earnings Forecast for Cardiovascular Systems, Inc. Issued By Leerink Swann (CSII)
www.americanbankingnews.com - October 30 at 9:20 AM
Cardiovascular Systems, Inc. Reports Fiscal 2018 First-Quarter Financial Results - Business Wire (press release)Cardiovascular Systems, Inc. Reports Fiscal 2018 First-Quarter Financial Results - Business Wire (press release)
www.businesswire.com - October 28 at 12:13 AM
Cardiovascular Systems (CSII) Q1 Earnings Top, Revenues Lag - NasdaqCardiovascular Systems (CSII) Q1 Earnings Top, Revenues Lag - Nasdaq
www.nasdaq.com - October 28 at 12:13 AM
Leerink Swann Comments on Cardiovascular Systems, Inc.s FY2019 Earnings (CSII)Leerink Swann Comments on Cardiovascular Systems, Inc.'s FY2019 Earnings (CSII)
www.americanbankingnews.com - October 27 at 7:30 PM
Edited Transcript of CSII earnings conference call or presentation 25-Oct-17 8:45pm GMTEdited Transcript of CSII earnings conference call or presentation 25-Oct-17 8:45pm GMT
finance.yahoo.com - October 26 at 2:41 PM
Cardiovascular Systems, Inc. (CSII) Given "Buy" Rating at Needham & Company LLCCardiovascular Systems, Inc. (CSII) Given "Buy" Rating at Needham & Company LLC
www.americanbankingnews.com - October 26 at 7:38 AM
Cardiovascular Systems, Inc. (CSII) Issues  Earnings Results, Beats Expectations By $0.01 EPSCardiovascular Systems, Inc. (CSII) Issues Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - October 25 at 9:20 PM
Cardiovascular Systems, Inc. to Host Earnings CallCardiovascular Systems, Inc. to Host Earnings Call
finance.yahoo.com - October 25 at 7:10 PM
Cardiovascular Systems, Inc. Reports Fiscal 2018 First-Quarter Financial ResultsCardiovascular Systems, Inc. Reports Fiscal 2018 First-Quarter Financial Results
finance.yahoo.com - October 25 at 7:10 PM
Cardiovascular Systems reports 1Q lossCardiovascular Systems reports 1Q loss
finance.yahoo.com - October 25 at 7:10 PM
Cardiovascular Systems, Inc. (CSII) Releases Q2 Earnings GuidanceCardiovascular Systems, Inc. (CSII) Releases Q2 Earnings Guidance
www.americanbankingnews.com - October 25 at 6:04 PM
Cardiovascular Systems (CSII) vs. The Competition Head to Head SurveyCardiovascular Systems (CSII) vs. The Competition Head to Head Survey
www.americanbankingnews.com - October 24 at 2:16 PM
Cardiovascular Systems, Inc. (CSII) Receives Consensus Rating of "Hold" from AnalystsCardiovascular Systems, Inc. (CSII) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - October 22 at 4:40 AM
Head-To-Head Survey: Cardiovascular Systems (CSII) vs. Its CompetitorsHead-To-Head Survey: Cardiovascular Systems (CSII) vs. Its Competitors
www.americanbankingnews.com - October 20 at 12:32 AM
Cardiovascular Systems (CSII) and VWR Corporation (VWR) Head-To-Head ComparisonCardiovascular Systems (CSII) and VWR Corporation (VWR) Head-To-Head Comparison
www.americanbankingnews.com - October 18 at 2:24 PM
ETFs with exposure to Cardiovascular Systems, Inc. : October 17, 2017ETFs with exposure to Cardiovascular Systems, Inc. : October 17, 2017
finance.yahoo.com - October 17 at 6:20 PM
Cardiovascular Systems, Inc. (CSII) to Release Quarterly Earnings on TuesdayCardiovascular Systems, Inc. (CSII) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - October 17 at 5:20 AM
Scott+Scott, Attorneys at Law, LLP Is Investigating Derivative Claims on Behalf of Shareholders of Cardiovascular ... - PR Newswire (press release)Scott+Scott, Attorneys at Law, LLP Is Investigating Derivative Claims on Behalf of Shareholders of Cardiovascular ... - PR Newswire (press release)
www.prnewswire.com - October 13 at 4:22 AM
Needham & Company LLC Reiterates "Buy" Rating for Cardiovascular Systems, Inc. (CSII)Needham & Company LLC Reiterates "Buy" Rating for Cardiovascular Systems, Inc. (CSII)
www.americanbankingnews.com - October 12 at 11:38 AM
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Cardiovascular Systems, Inc. for Potential ... - PR Newswire (press release)SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Cardiovascular Systems, Inc. for Potential ... - PR Newswire (press release)
www.prnewswire.com - October 11 at 7:06 PM
-$0.07 Earnings Per Share Expected for Cardiovascular Systems, Inc. (CSII) This Quarter-$0.07 Earnings Per Share Expected for Cardiovascular Systems, Inc. (CSII) This Quarter
www.americanbankingnews.com - October 11 at 4:30 AM
Cardiovascular Systems, Inc. (CSII) Downgraded by Zacks Investment ResearchCardiovascular Systems, Inc. (CSII) Downgraded by Zacks Investment Research
www.americanbankingnews.com - October 10 at 10:46 PM

SEC Filings

Cardiovascular Systems (NASDAQ:CSII) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Cardiovascular Systems (NASDAQ:CSII) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Cardiovascular Systems (NASDAQ CSII) Stock Chart for Saturday, January, 20, 2018

Loading chart…

This page was last updated on 1/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.